1. Suratman S, Edwards JW, Babina K. Organophosphate pesticides exposure among farmworkers: pathways and risk of adverse health effects. Rev Environ Health 2015;30(1):65-79. PubMed [
DOI:10.2147/RMHP.S97733]
2. Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol 2013;268(2):157-77. PubMed [
DOI:10.1016/j.taap.2013.01.025]
3. McCauley LA, Anger WK, Keifer M, Langley R, Robson MG, Rohlman D. Studying health outcomes in farmworker populations exposed to pesticides. Environ Health Perspect 2006:114(6)953-60. PubMed [
DOI:10.1289/ehp.8526]
4. Kamel F, Hoppin JA. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 2004:112(9):950-8. PubMed [
DOI:10.1289/ehp.7135]
5. Alavanja MC, Hoppin JA, Kamel F. Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health 2004;25:155-97. PubMed [
DOI:10.1146/annurev.publhealth.25.101802.123020]
6. Voorhees JR, Rohlman DS, Lein PJ, Pieper AA. Neurotoxicity in preclinical models of occupational exposure to organophosphorus compounds. Front Neurosci 2017;10:590. PubMed [
DOI:10.3389/fnins.2016.00590]
7. Mehrpour O, Karrari P, Zamani N, Tsatsakis AM, Abdollahi M. Occupational exposure to pesticides and consequences on male semen and fertility: A review. Toxicol Lett 2014;230(2):146-56. PubMed [
DOI:10.1016/j.toxlet.2014.01.029]
8. Muñoz-Quezada MT, Lucero BA, Iglesias VP, Muñoz MP, Cornejo CA, Achu E, et al. Chronic exposure to organophosphate (OP) pesticides and neuropsychological functioning in farm workers: a review. International J Occup Environ Health 2016;22(1):68-79. PubMed [
DOI:10.1080/10773525.2015.1123848]
9. Muñoz-Quezada MT, Lucero B, Iglesias V, Levy K, Muñoz MP, Achú E, et al. Exposure to organophosphate (OP) pesticides and health conditions in agricultural and non-agricultural workers from Maule, Chile. Int J Environ Health Res 2017;27(1):82-93. PubMed [
DOI:10.1080/09603123.2016.1268679]
10. Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol 1998;31(3):329-36. PubMed [
DOI:10.1016/S0306-3623(98)00028-7]
11. Meek EC, Chambers HW, Pringle RB, Chambers JE. The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats. Toxicology 2015;336:79-83. PubMed [
DOI:10.1016/j.tox.2015.08.002]
12. Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci 2012;4(11):523-32. PubMed [
DOI:10.4103/1947-2714.103310]
13. La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1988;43(3):227-9. PubMed
14. Afolabi OK, Wusu AD, Ogunrinola OO, Abam EO, Babayemi DO, Dosumu OA, et al. Paraoxonase 1 activity in subchronic low-level inorganic arsenic exposure through drinking water. Environ Toxicol 2016;31(2):154-62. PubMed [
DOI:10.1002/tox.22030]
15. Devarajan A, Shih D, Reddy ST. Inflammation, infection, cancer and all that...the role of paraoxonases. Adv Exp Med Biol 2014;824:33-41. PubMed [
DOI:10.1007/978-3-319-07320-0_5]
16. Camps J, García-Heredia A, Hernández-Aguilera A, Joven J. Paraoxonases, mitochondrial dysfunction and non-communicable diseases. Chem Biol Interact 2016;259(Pt B):382-7. PubMed [
DOI:10.1016/j.cbi.2016.04.005]
17. Gawade G, Melinkeri R. Oxidative Stress and Paraoxonase (PON-1) Status in Diabetic Nephropathy. Int J Health Sci Res 2015;5(12):177-84. Link
18. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37(9):1304-16. PubMed [
DOI:10.1016/j.freeradbiomed.2004.06.030]
19. Costa C, Gangemi S, Giambò F, Rapisarda V, Caccamo D, Fenga C. Oxidative stress biomarkers and paraoxonase 1 polymorphism frequency in farmers occupationally exposed to pesticides. Mol Med Rep 2015;12(4):6353-7. PubMed [
DOI:10.3892/mmr.2015.4196]
20. Ranjbar A, Pasalar P, Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum Exp Toxicol 2002;21(4):179-82. PubMed [
DOI:10.1191/0960327102ht238oa]
21. Zepeda-Arce R, Rojas-Garcia AE, Benitez-Trinidad A, Herrera-Moreno JF, Medina-Diaz IM, Barron-Vivanco BS, et al. Oxidative stress and genetic damage among workers exposed primarily to organophosphate and pyrethroid pesticides. Environ Toxicol 2017;32(6):1754-64. PubMed [
DOI:10.1002/tox.22398]
22. Costa LG, Cole TB, Vitalone A, Furlong CE. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin Chim Acta 2005;352(1):37-47. PubMed [
DOI:10.1016/j.cccn.2004.09.019]
23. Costa LG, Richter RJ, Li W-F, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 2003;8(1):1-12. PubMed [
DOI:10.1080/13547500210148315]
24. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7(2):88-95. Link [
DOI:10.1016/0006-2952(61)90145-9]
25. Ramirez-Santana M, Farias-Gomez C, Zuniga-Venegas L, Sandoval R, Roeleveld N, Van der Velden K, et al. Biomonitoring of blood cholinesterases and acylpeptide hydrolase activities in rural inhabitants exposed to pesticides in the Coquimbo Region of Chile. PloS one 2018;13(5):e0196084. Link [
DOI:10.1371/journal.pone.0196084]
26. El-Demerdash FM, Nasr HM. Antioxidant effect of selenium on lipid peroxidation, hyperlipidemia and biochemical parameters in rats exposed to diazinon. J Trace Elem Med Biol 2014;28(1):89-93. PubMed [
DOI:10.1016/j.jtemb.2013.10.001]
27. Ceron JJ, Tecles F, Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet Res 2014;10(1):74. PubMed [
DOI:10.1186/1746-6148-10-74]
28. Eckerson HW, Romson J, Wyte C, La Du B. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983;35(2):214. PubMed
29. Eckerson HW, Wyte CM, La Du B. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126. PubMed
30. Kapka-Skrzypczak L, Cyranka M, Skrzypczak M, Kruszewski M. Biomonitoring and biomarkers of organophosphate pesticides exposure - state of the art. Ann Agric Environ Med 2011;18(2):294-303. PubMed
31. Lionetto MG, Caricato R, Calisi A, Giordano ME, Schettino T. Acetylcholinesterase as a biomarker in environmental and occupational medicine: new insights and future perspectives Biomed Res Int 2013;2013 :321213. PubMed [
DOI:10.1155/2013/321213]
32. He F. Biological monitoring of exposure to pesticides: current issues. Toxicol Lett 1999;108(2-3):277-83. PubMed [
DOI:10.1016/S0378-4274(99)00099-5]
33. Dasgupta S, Meisner C, Wheeler D, Xuyen K, Thi Lam N. Pesticide poisoning of farm workers-implications of blood test results from Vietnam. Int J Hyg Environ Health 2007;210(2):121-32. PubMed [
DOI:10.1016/j.ijheh.2006.08.006]
34. Surajudeen YA, Sheu RK, Ayokulehin KM, Olatunbosun AG. Oxidative stress indices in Nigerian pesticide applicators and farmers occupationally exposed to organophosphate pesticides. Int J Appl Basic Med Res 2014;4(Suppl 1): S37-40. PubMed [
DOI:10.4103/2229-516X.140730]
35. Atherton KM, Williams FM, Egea Gonzalez FJ, Glass R, Rushton S, Blain PG, et al. DNA damage in horticultural farmers: a pilot study showing an association with organophosphate pesticide exposure. Biomarkers 2009;14(7):443-51. PubMed [
DOI:10.3109/13547500903137265]
36. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol 1998;18(10):1617-24. PubMed [
DOI:10.1161/01.ATV.18.10.1617]
37. Sorenson RC, Primo-Parmo SL, Kuo CL, Adkins S, Lockridge O, La Du BN. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc Natl Acad Sci U S A 1995;92(16):7187-91. PubMed [
DOI:10.1073/pnas.92.16.7187]
38. Sozmen EY, Sagin FG, Kayikcioglu M, Sozmen B. Oxidative stress & antioxidants and PON1 in health and disease. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism. Springer; 2008. p. 61-73. [
DOI:10.1007/978-1-4020-6561-3_4]